Grants and Contributions:
Title:
New platform for toxicity and efficacy testing of biopharmaceutical compounds on human innervated skin-on-a-chip
Agreement Number:
948556
Agreement Value:
$295,000.00
Agreement Date:
May 1, 2020 - Sep 24, 2021
Description:
Ananda Devices will develop new platforms to scale up production of human models of skin-on-a-chip to enable biopharmaceutical industries to more efficiently test toxicity and efficacy of their products without using animals.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H4R 3E9
Reference Number:
172-2020-2021-Q1-948556
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
799217898
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 65,000 dollars.
Amendment Date
Mar 25, 2021
Recipient's Operating Name:
ANANDA Devices
Recipient's Legal Name:
9493662 CANADA Inc
Federal Riding Name:
Saint-Laurent
Federal Riding Number:
24068
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54199
Amendments: